Thongprayoon, C.; Kaewput, W.; Petnak, T.; O’Corragain, O.A.; Boonpheng, B.; Bathini, T.; Vallabhajosyula, S.; Pattharanitima, P.; Lertjitbanjong, P.; Qureshi, F.;
et al. Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States. Medicines 2021, 8, 21.
https://doi.org/10.3390/medicines8050021
AMA Style
Thongprayoon C, Kaewput W, Petnak T, O’Corragain OA, Boonpheng B, Bathini T, Vallabhajosyula S, Pattharanitima P, Lertjitbanjong P, Qureshi F,
et al. Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States. Medicines. 2021; 8(5):21.
https://doi.org/10.3390/medicines8050021
Chicago/Turabian Style
Thongprayoon, Charat, Wisit Kaewput, Tananchai Petnak, Oisin A. O’Corragain, Boonphiphop Boonpheng, Tarun Bathini, Saraschandra Vallabhajosyula, Pattharawin Pattharanitima, Ploypin Lertjitbanjong, Fawad Qureshi,
and et al. 2021. "Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States" Medicines 8, no. 5: 21.
https://doi.org/10.3390/medicines8050021
APA Style
Thongprayoon, C., Kaewput, W., Petnak, T., O’Corragain, O. A., Boonpheng, B., Bathini, T., Vallabhajosyula, S., Pattharanitima, P., Lertjitbanjong, P., Qureshi, F., & Cheungpasitporn, W.
(2021). Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States. Medicines, 8(5), 21.
https://doi.org/10.3390/medicines8050021
